The Role of Human Epidermal Growth Factor Receptor (HER2/neu) in the Prognosis of Patients with Gastric Cancer.

CONCLUSION: Evaluation of HER2/neu status in gastric cancer patients<br />showed that HER2/neu 3+ expression could reduce the patients' survival. Therefore, it is recommended that patients<br />who may benefit from trastuzumab, be treated. A clinical multi-center trial should be also considered for use of this<br />drug in adjuvant cases. PMID: 31350955 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research